Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - atenolol, quantity: 50 mg - tablet, film coated - excipient ingredients: maize starch; magnesium carbonate hydrate; magnesium stearate; gelatin; sodium lauryl sulfate; titanium dioxide; lactose monohydrate; hypromellose; macrogol 4000 - atenolol sandoz is indicated in the management of:,- all grades of hypertension, including hypertension of renal origin,- frequent disabling angina without evidence of cardiac failure,- cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias, including those associated with acute myocardial infarction),- myocardial infarction: late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain).

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - atenolol, quantity: 50 mg - tablet, film coated - excipient ingredients: magnesium carbonate hydrate; sodium starch glycollate type a; colloidal anhydrous silica; maize starch; sodium lauryl sulfate; magnesium stearate; hypromellose; macrogol 6000; titanium dioxide; purified talc - atenolol is indicated in the management of:,(i) all grades of hypertension, including hypertension of renal origin. (ii) frequent disabling angina without evidence of cardiac failure. (iii) cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those associated with acute myocardial infarction), (iv) myocardial infarction - late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain)

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - atenolol, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: propylene glycol; propyl hydroxybenzoate; saccharin sodium; purified water; citric acid monohydrate; sorbitol solution (70 per cent) (non-crystallising); sodium citrate dihydrate; methyl hydroxybenzoate; flavour - all grades of hypertension including hypertension of renal origin.,frequent disabling angina without evidence of cardiac failure,cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those with acute myocardial infarction),myocardial infarction - late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain)

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - atenolol -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - atenolol -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - atenolol -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - atenolol -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - atenolol -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - atenolol -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - atenolol -